doi.org/10.1530/eje.0.1490443, hdl.handle.net/1765/56033
European Journal of Endocrinology
Department of Internal Medicine

Weetman, A., Shepherdley, C., Mansell, P., Ubhi, C., & Visser, T. (2003). Thyroid over-expression of type 1 and type 2 deiodinase may account for the syndrome of low thyroxine and increasing triiodothyronine during propylthiouracil treatment. European Journal of Endocrinology, 149(5), 443–447. doi:10.1530/eje.0.1490443